UNSPSC 51302604: Ambruticin

This classification denotes an antifungal agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X794618736. European Medicines Agency schedules Ambruticin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05398MIG. Ambruticin generally arises in the molecular formula C28H42O6.

UNSPSC 51302604 Ambruticin is a Commodity code identifying a specific pharmaceutical product, but the only recent state and local opportunity tagged with this code—the City of Tampa Fire Rescue Department's ITB 25-P-00157 for medical aid supplies—does not solicit ambruticin itself. The Tampa bid requests a broad range of first aid and medical consumables including antiseptic sprays, hydrogen peroxide, aspirin, pain relievers, bandages, first aid kits, and emergency blankets for fire rescue operations, with estimated annual volumes ranging from 1 to 2,700 units per item and a total department budget of $100,000. The code shows little relevant recent activity aligned with its nominal scope. The mismatch suggests that ambruticin procurement through state and local channels may be either minimal, handled under broader pharmaceutical or medical supply codes, or not currently active in the tracked opportunity set.

The single opportunity on record is issued by the City of Tampa through its purchasing office and includes local set-asides for City-certified Small Local Business Enterprises (SLBEs) and Underutilized Woman and Minority Owned Business Enterprises (U-WMBEs), offering bid discounts capped at $10,000 for SLBEs and $20,000 for U-WMBEs. The ITB closed April 9, 2025, with evaluation criteria including product quality, vendor responsibility, and compliance with local ordinances; all medications must maintain a minimum nine-month expiration date from acceptance. The solicitation structure allows award by aggregate total or individual line items, with an initial one-year period and two potential one-year renewals. Without additional recent opportunities under this code, geographic concentration or issuing-body patterns cannot be characterized.